search
Back to results

mHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes (ENERGISED)

Primary Purpose

Type 2 Diabetes, PreDiabetes

Status
Recruiting
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
mHealth
phone counselling
Fitbit tracker
brief advice
Sponsored by
Charles University, Czech Republic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Type 2 Diabetes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of prediabetes or T2DM according to the Czech guidelines for GPs on diabetes mellitus1 and prediabetes2, i.e. fasting plasma glucose 5.6-6.9 mmol/l, or 2-h plasma glucose of 7.8-11.0 mmol/l after ingestion of 75 g of oral glucose load for the diagnosis of prediabetes, and fasting plasma glucose ≥ 7.0 mmol/l, or 2-h plasma glucose ≥ 11.1 mmol/l after ingestion of 75 g of the oral glucose load for the diagnosis of T2DM
  • Age 18 years or older.
  • Registered at a participating general practice.
  • Regular users of a smartphone and willing to use it as part of the study.
  • Written informed consent obtained before any assessment related to the study.

Exclusion Criteria:

  • unable to walk
  • pregnancy
  • taking insulin
  • living in a residential or nursing care home
  • co-morbid conditions that would affect their adherence to the trial procedures

Sites / Locations

  • Institute of General PracticeRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Active control

Intervention

Arm Description

The patients from the active control group will receive brief physical activity advice from their general practitioners at baseline, and they will also receive the Fitbit tracker to self-monitor their daily steps.

The patients in the intervention group will be exposed to the same procedures as those from the active control group, but will also receive a mHealth-enabled just-in-time adaptive intervention and regular monthly phone counselling in the first 6 months.

Outcomes

Primary Outcome Measures

step count
change in daily step count

Secondary Outcome Measures

chair-stand test
functional 30s chair-stand test
HbA1c
haemoglobin A1c
glycemia
fasting plasma glucose
lipid profile
total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerids
step count
change in daily step count
physical behaviour - average acceleration
metric of physical activity volume
physical behaviour - intensity gradient
metric of physical activity intensity
sedentary time
time per day spent sedentary (in minutes)
sedentary bouts
time per day (in minutes) spent sedentary in bouts of 30 mins and longer
walking cadence
cadence (steps/min) in 5 (non-consecutive) highest-cadence minutes
blood pressure
systolic and diastolic blood pressure
Hospital Anxiety and Depression Scale (HADS)
symptoms of anxiety and depression: 14 items on a scale 0-3 (a higher score means a worse outcome)
Short Form Survey (SF-12)
measure of health-related quality of life: 12 items using various scales converted to a score 0-100 (a higher score means a better outcome)
body mass index
weigh in kilograms divided by height in meters squared

Full Information

First Posted
April 19, 2022
Last Updated
October 3, 2022
Sponsor
Charles University, Czech Republic
Collaborators
University of Hradec Kralove, St George's, University of London, University of Leicester, University Ghent
search

1. Study Identification

Unique Protocol Identification Number
NCT05351359
Brief Title
mHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes
Acronym
ENERGISED
Official Title
mHealth Intervention Delivered in General Practice to Increase Physical Activity and Reduce Sedentary Behaviour of Patients With Prediabetes and Type 2 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 25, 2022 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
June 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Charles University, Czech Republic
Collaborators
University of Hradec Kralove, St George's, University of London, University of Leicester, University Ghent

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Sedentary behaviour has a detrimental effect on the mortality, morbidity, and well-being of patients with type 2 diabetes and prediabetes, and general practitioners should advise patients on how to self-monitor and increase their physical activity. The emergence of mobile health (mHealth) technologies unlocks the potential to further improve physical behaviour using an innovative "just-in-time" adaptive approach whereby behavioural support is provided in real-time, based on data from wearable sensors. Thus, the investigators aim to evaluate the effect of a just-in-time mHealth intervention administered by general practitioners on the physical activity and sedentary behaviour of patients with type 2 diabetes and prediabetes. A total of 340 patients will be recruited from 20 general practices across the Czech Republic and randomly assigned to either an active control or intervention group. Both groups will receive brief physical activity advice from their general practitioners and a Fitbit fitness tracker to self-monitor their daily steps, but the intervention group will also receive a mHealth-enabled just-in-time adaptive intervention and regular monthly phone counselling in the first 6 months. The mHealth intervention will be delivered using a custom-developed system (HealthReact) connected to the Fitbit that will trigger just-in-time text messages. For example, a prompt to take a break from sedentary behaviour will be triggered after 30 sedentary minutes or a motivational message with a specific goal to take more steps will be triggered when the total step count is too low. The primary outcome will be the change in daily step count at 6 months, other outcomes include changes in other physical behaviour measures, blood tests, anthropometry and patient-reported outcomes at 6 and 12 months. If the intervention is effective, this study will provide a model of health prevention that can be directly implemented and commissioned within primary care using existing infrastructure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes, PreDiabetes

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
340 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active control
Arm Type
Active Comparator
Arm Description
The patients from the active control group will receive brief physical activity advice from their general practitioners at baseline, and they will also receive the Fitbit tracker to self-monitor their daily steps.
Arm Title
Intervention
Arm Type
Experimental
Arm Description
The patients in the intervention group will be exposed to the same procedures as those from the active control group, but will also receive a mHealth-enabled just-in-time adaptive intervention and regular monthly phone counselling in the first 6 months.
Intervention Type
Behavioral
Intervention Name(s)
mHealth
Intervention Description
A mHealth-enabled just-in-time adaptive intervention that is based on the HealthReact system developed by the participating centre at the Faculty of Science of the University of Hradec Kralove. The HealthReact system consists of a server-side application that is connected to the Fitbit server. As such, the system allows for just-in-time text messages triggered by pre-defined context as recorded by the Fitbit wearable monitor. For example, a prompt to take a break from sedentary behaviour can be triggered after 30 sedentary minutes, a suggestion to increase walking cadence can be triggered when continuous, but slow walking is detected, or a motivational message with a specific goal to take more steps to reach their usual daily step count can be triggered when the total daily steps are too low. The mHealth component will be delivered for the entire duration of the study (i.e., 12 months).
Intervention Type
Behavioral
Intervention Name(s)
phone counselling
Intervention Description
Regular monthly phone calls by trained counsellors support participants in their effort to increase physical activity and reduce sedentary behaviours. The counsellors will use various behaviour change techniques, such as goal-setting, feedback, action planning, etc. The phone counselling will be provided during the first six months, i.e. 6 phone calls will be delivered.
Intervention Type
Behavioral
Intervention Name(s)
Fitbit tracker
Intervention Description
Fitbit Inspire 2 will be provided by the general practitioner to study participants at the start of the study to enable objective self-monitoring of physical activity.
Intervention Type
Behavioral
Intervention Name(s)
brief advice
Intervention Description
A brief advice will be provided by the general practitioner at the start of the study.
Primary Outcome Measure Information:
Title
step count
Description
change in daily step count
Time Frame
from baseline to 12-month assessment
Secondary Outcome Measure Information:
Title
chair-stand test
Description
functional 30s chair-stand test
Time Frame
at 6 and 12 months
Title
HbA1c
Description
haemoglobin A1c
Time Frame
at 6 and 12 months
Title
glycemia
Description
fasting plasma glucose
Time Frame
at 6 and 12 months
Title
lipid profile
Description
total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerids
Time Frame
at 12 months
Title
step count
Description
change in daily step count
Time Frame
at 6 months
Title
physical behaviour - average acceleration
Description
metric of physical activity volume
Time Frame
at 6 and 12 months
Title
physical behaviour - intensity gradient
Description
metric of physical activity intensity
Time Frame
at 6 and 12 months
Title
sedentary time
Description
time per day spent sedentary (in minutes)
Time Frame
at 6 and 12 months
Title
sedentary bouts
Description
time per day (in minutes) spent sedentary in bouts of 30 mins and longer
Time Frame
at 6 and 12 months
Title
walking cadence
Description
cadence (steps/min) in 5 (non-consecutive) highest-cadence minutes
Time Frame
at 6 and 12 months
Title
blood pressure
Description
systolic and diastolic blood pressure
Time Frame
at 6 and 12 months
Title
Hospital Anxiety and Depression Scale (HADS)
Description
symptoms of anxiety and depression: 14 items on a scale 0-3 (a higher score means a worse outcome)
Time Frame
at 6 and 12 months
Title
Short Form Survey (SF-12)
Description
measure of health-related quality of life: 12 items using various scales converted to a score 0-100 (a higher score means a better outcome)
Time Frame
at 6 and 12 months
Title
body mass index
Description
weigh in kilograms divided by height in meters squared
Time Frame
at 6 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of prediabetes or T2DM according to the Czech guidelines for GPs on diabetes mellitus1 and prediabetes2, i.e. fasting plasma glucose 5.6-6.9 mmol/l, or 2-h plasma glucose of 7.8-11.0 mmol/l after ingestion of 75 g of oral glucose load for the diagnosis of prediabetes, and fasting plasma glucose ≥ 7.0 mmol/l, or 2-h plasma glucose ≥ 11.1 mmol/l after ingestion of 75 g of the oral glucose load for the diagnosis of T2DM Age 18 years or older. Registered at a participating general practice. Regular users of a smartphone and willing to use it as part of the study. Written informed consent obtained before any assessment related to the study. Exclusion Criteria: unable to walk pregnancy taking insulin living in a residential or nursing care home co-morbid conditions that would affect their adherence to the trial procedures
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tomas Vetrovsky, MD, PhD
Phone
+420724600710
Email
tomas.vetrovsky@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bohumil Seifert, MD, PhD
Organizational Affiliation
Charles University
Official's Role
Study Chair
Facility Information:
Facility Name
Institute of General Practice
City
Prague
Country
Czechia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bohumil Seifert

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

mHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes

We'll reach out to this number within 24 hrs